Seres Therapeutics soared as much as 608% on Monday after the company announced positive phase 3 trial data for its drug SER-109 was de…
Seres Therapeutics soared as much as 608% on Monday after the company announced positive phase 3 trial data for its drug SER-109 was de…
Comments are closed.